Krabbe disease: Genetic aspects and progress toward therapy

Molecular Genetics and Metabolism

Volumn 70, Issue 1, 2000, Pages 1-9

  Wenger, David A ^a   Rafi, Mohammad A ^a   Luzi, Paola ^a   Datto, Jeffrey ^a   Costantino Ceccarini, Elvira ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b CNR   (Italy)

Author keywords

Galactocerebrosidase; Galactosylceramide; Globoid cell leukodystrophy; Krabbe disease; Myelin; Olig odendrocyte; Psychosine; Stem cells

Indexed keywords

GALACTOSYLCERAMIDASE; GALACTOSYLCERAMIDE; LYSOSOME ENZYME; MYELIN; PSYCHOSINE;

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; GENE MUTATION; GENE THERAPY; GENETIC POLYMORPHISM; GLOBOID CELL LEUKODYSTROPHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0034043008     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2000.2990     Document Type: Article

References (48)

1. Wenger D A. Krabbe disease (globoid cell leukodystrophy). Rosenberg RN Prusiner S, DiMauro S Barchi RL. The Molecular and Genetic Basis of Neurological Disease. 1997;421-431 Butterworth-Heinemann, Boston.
2. Wenger, D, A, Suzuki, K, Suzuki, Y, Suzuki, K, Galactosylceramide lipidosis. Globoid cell leukodystrophy (Krabbe disease). In, The Metabolic and Molecular Bases of Inherited Disease, 8th ed. (, Scriver, C, R, Beaudet, A, L, Sly, W, AS, Valle, D, Childs, B, Vogelstein, B, Eds.), New York, McGraw-Hill, in press.
3. Yeager A M, Brennan S, Tiffany C, Moser H W, Santos G W. Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse. Science. 225:1984;1053-1054.
4. Krivit W, Shapiro E G, Peters C, Wagner J E, Cornu G, Kurtzberg J, Wenger D A, Kolodny E H, Vanier M T, Loes D J, Dusenbery K, Lockman L A. Hematopoietic stem-cell transplantation in globoid cell leukodystrophy. New Engl J Med. 338:1998;1119-1126.
5. Krabbe K. A new familial, infantile form of diffuse brain sclerosis. Brain. 39:1916;74-114.
6. Hagberg B, Kollberg H, Sourander P, Akesson H O. Infantile globoid cell leucodystrophy (Krabbe's disease): A clinical and genetic study of 32 Swedish cases 1953-1967. Neuropaediatrie. 1:1970;74-88.
7. Crome L, Hanefield F, Patrick D, Wilson J. Late onset globoid cell leucodystrophy. Brain. 96:1973;841-848.
8. Thomas P K, Halpern J-P, King R HM, Patrick P. Galactosylceramide lipidosis: Novel presentation as a slowly progressive spinocerebellar degeneration. Ann Neurol. 16:1984;618-620.
9. Vanier M. Symptomatology of late onset Krabbe's leukodystrophy: The European experience. Dev Neurosci. 13:1991;240-244.
10. Verdu P, Lammens M, Dom R, Van Elsen A, Carton H. Globoid cell leukodystrophy: A family with both late-infantile and adult type. Neurology. 41:1991;1382-1384.
11. Kolodny E H, Raghavan S, Krivit W. Late-onset Krabbe disease (globoid cell leukodystrophy): Clinical and biochemical features of 15 cases. Dev Neurosci. 13:1991;232-239.
12. Luzi P, Rafi M A, Wenger D A. Multiple mutations in the GALC gene in a patient with adult-onset Krabbe disease. Ann Neurol. 40:1996;116-119.
13. Satoh J-I, Tokumoto H, Kurohara K, Yukitake M, Matsui M, Kuroda Y, Yamamoto T, Furuya H, Shinnoh N, Kobayashi T, Kukita Y, Hayashi K. Adult-onset Krabbe disease with homozygous T1853C mutation in the galactocerebrosidase gene. Neurology. 49:1997;1392-1399.
14. Jardim L B, Giugliani R, Pires R F, Haussen S, Burin M G, Rafi M A, Wenger D A. Protracted course of Krabbe disease in an adult patient bearing a novel mutation. Arch Neurol. 56:1999;1014-1017.
15. Wenger D A, Rafi M A, Luzi P. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): Diagnostic and clinical implications. Hum Mutat. 10:1997;268-279.
16. Fu L, Inui K, Nishigaki T, Tatsumi N, Tsukamoto H, Kokubu C, Muramatsu T, Okada S. Molecular heterogeneity of Krabbe disease. J Inher Metab Dis. 22:1999;155-162.
17. Chen Y Q, Rafi M A, de Gala G, Wenger D A. Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy. Hum Molec Genet. 2:1993;1841-1845.
18. Sakai N, Inui K, Fujii N, Fukushima H, Nishimoto J, Yanagihara I, Isegawa Y, Iwamatsu A, Okada S. Krabbe disease: Isolation and characterization of a full-length cDNA for human galactocerebrosidase. Biochem Biophys Res Commun. 198:1994;485-491.
19. Luzi P, Rafi M A, Wenger D A. Structure and organization of the human galactocerebrosidase (GALC) gene. Genomics. 26:1995;407-409.
20. Luzi P, Victoria T, Rafi M A, Wenger D A. Analysis of the 5′ flanking region of the human galactocerebrosidase (GALC) gene. Biochem Molec Med. 62:1997;159-164.
21. Sakai N, Fukushima H, Inui K, Fu L, Nishigaki T, Inui K, Fu L, Nishigaki T, Yanagihara I, Tatsumi N, Ozono K, Okada S. Human galactocerebrosidase gene: Promoter analysis of the 5′-flanking region and structural organization. Biochim Biophys Acta. 1395:1998;62-67.
22. Chen Y Q, Wenger D A. Galactocerebrosidase from human urine: Purification and partial characterization. Biochim Biophys Acta. 1170:1993;53-61.
23. Sakai N, Inui K, Midorikawa M, Okuno Y, Ueda S, Iwamatsu A, Okada S. Purification and characterization of galactocerebrosidase from human lymphocytes. J Biochem. 116:1994;615-620.
24. Nagano S, Yamada T, Shinnoh N, Furuya H, Taniwaki T, Kira J. Expression and processing of recombinant human galactosylceramidase. Clin Chim Acta. 272:1998;53-61.
25. Rafi M A, Luzi P, Chen Y Q, Wenger D A. A large deletion together with a point mutation in the GALC gene is a common mutant allele in patients with infantile Krabbe disease. Hum Molec Genet. 4:1995;1285-1289.
26. Luzi P, Rafi M A, Wenger D A. Characterization of the large deletion in the GALC gene found in patients with Krabbe disease. Hum Molec Genet. 4:1995;2335-2338.
27. Ichioka T, Kishimoto Y, Brennan S, Santos G W, Yeager A M. Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse): Effects on levels of galactosylceramidase, psychosine, and galactocerebrosides. Proc Natl Acad Sci USA. 84:1987;4259-4263.
28. Hoogerbrugge P M, Poorthuis B J, Romme A RE, van de Kamp J J, Wagemaker G, van Bekkum D W. Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse. J Clin Invest. 81:1988;1790-1794.
29. Hoogerbrugge P M, Suzuki K, Suzuki K, Poorthuis B JHM, Kobayashi T, Wagemaker G, Bekkum D WV. Donor derived cells in the central nervous system of twitcher mice after bone marrow transplantation. Science. 239:1988;1035-1038.
30. Huppes W, De Groot C J, Ostendorf R H, Bauman J G, Gossen J A, Smit V, Vijg J, Dijkstra C D. Detection of migrated allogeneic oligodendrocytes throughout the central nervous system of the galactocerebrosidase-deficient twitcher mouse. J Neurocytol. 21:1992;129-136.
31. Matsumoto A, Vanier M T, Oya Y, Kelly D, Popko B, Wenger D A, Suzuki K, Suzuki K. Transgenic introduction of human galactosylceramidase into twitcher mouse: Significant phenotype improvement with a minimal expression. Dev Brain Dysfunc. 10:1998;142-154.
32. Rafi M A, Fugaro J, Amini S, Luzi P, de Gala G, Victoria T, Dubell C, Shahinfar M, Wenger D A. Retroviral vector-mediated transfer of the galactocerebrosidase (GALC) cDNA leads to overexpression and transfer of GALC activity to neighboring cells. Biochem Molec Med. 58:1996;142-150.
33. Gama Sosa M A, De Gasperi R, Undevia S, Yeretsian J, Rouse SC I I, Lyerla T A, Kolodny E H. Correction of the galactocerebrosidase deficiency in globoid cell leukodystrophy-cultured cells by SL-3 retroviral-mediated gene transfer. Biochem Biophys Res Commun. 218:1996;766-771.
34. Costantino-Ceccarini E, Luddi A, Volterrani M, Strazza M, Rafi M A, Wenger D A. Transduction of cultured oligodendrocytes from normal and twitcher mice by a retroviral vector containing human galactocerebrosidase (GALC) cDNA. Neurochem Res. 24:1999;287-293.
35. Bambach B J, Moser H W, Blakemore K J, Corson V L, Griffin C A, Noga S J, Perlman E J, Zuckerman R, Wenger D A, Jones R J. Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy. Bone Marrow Transplant. 19:1997;399-402.
36. Taniike M, Mohri I, Eguchi N, Irikura D, Urade Y, Okada S, Suzuki K. An apoptotic depletion of oligodendrocytes in the twitcher, a murine model of globoid cell leukodystrophy. J Neuropathol Exp Neurol. 58:1999;644-653.
37. Suzuki K. Twenty-five years of the "psychosine hypothesis": A personal perspective of its history and present status. Neurochem Res. 23:1998;251-259.
38. Ghodsi A, Stein C, Derksen T, Yang G, Andersson R D, Davison B L. Extensive β-glucuronidase activity in murine central nervous system after adenovirus-mediated gene transfer to brain. Hum Gene Ther. 9:1998;2331-2340.
39. Skorupa A F, Fisher K J, Wilson J M, Parente M K, Wolfe J H. Sustained production of β-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. Exp Neurol. 160:1999;17-27.
40. Bosch A, Perret E, Desmaris N, Heard J M. Long-term and significant correction of brain lesions in adult mucopolysaccharidosis Type VII mice using recombinant AAV vectors. Molec Ther. 1:2000;63-70.
41. Johe K K, Hazel T G, Muller T, Dugich-Djordjevic M M, McKay R DG. Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Dev. 10:1996;3129-3140.
42. McKay R. Stem cells in the central nervous system. Science. 276:1997;66-71.
43. Azizi S A, Stokes D, Augelli B J, DiGirolamo C, Prockop D J. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats - Similarities to astrocyte grafts. Proc Natl Acad Sci USA. 95:1998;3908-3913.
44. Ourednik V, Ourednik J, Park K I, Snyder E Y. Neural stem cells - A versatile tool for cell replacement and gene therapy in the central nervous system. Clin Genet. 56:1999;267-278.
45. Brustle O, Jones K N, Learish R D, Karram K, Choudhary K, Wiestler O D, Duncan I D, McKay R D. Embryonic stem cell-derived glial precursors: A source of myelinating transplants. Science. 285:1999;754-756.
46. Yandava B D, Billinghurst L L, Snyder E Y. "Global" cell replacement is feasible via neural stem cell transplantation: Evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci USA. 96:1999;7029-7034.
47. Torchiana E, Lulli L, Cattaneo E, Invernizzi F, Orefice R, Bertagnolio B, Di Donato S, Finocchiaro. Retroviral-mediated transfer of the galactocerebrosidase gene in neural progenitor cells. NeuroReport. 9:1998;3823-3827.
48. Wenger D A, Snyder E Y, Taylor R M, Vanier M T, Rafi M A, Luzi P, Datto J. Neural stem cells for the treatment of the twitcher mouse model of Krabbe disease. Am J Hum Genet. 65:1999;A116.